David Dowdy

Causality of Post-TB Lung Disease: Population-Level Evidence from Rural Uganda

National Institute of Allergy and Infectious Diseases · R01

Contact PI · $1.9M · Johns Hopkins University

Options for Delivery of Short-Course Tuberculosis Preventive Therapy: The 3HP Options Trial

National Heart, Lung, and Blood Institute · R01

PI · $4.4M · University of California-Irvine

JHU TRAC: Training and Supporting the Next Generation of TB Researchers

National Institute of Allergy and Infectious Diseases · P30

Project lead · $506.7K · Johns Hopkins University

Hotspot Versus Clinic-Based Active Case Finding for TB in Uganda: A Pragmatic Randomized Trial

National Heart, Lung, and Blood Institute · R01

Contact PI · $5.4M · Johns Hopkins University

A Clinical Risk Score for Early Management of TB in Uganda

Principal investigator · Completed

Johns Hopkins Bloomberg School of Public Health

Kharituwe TB Contact Tracing Study

Principal investigator · Completed

Johns Hopkins Bloomberg School of Public Health

Options for Delivering Isoniazid-Rifapentine (3HP) for TB Prevention (3HP Options Implementation Trial)

Principal investigator · Completed

University of California, San Francisco

Comparative Effectiveness/Implementation of TB Case Finding in Rural South Africa

Principal investigator · Completed

Johns Hopkins Bloomberg School of Public Health